1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62C29EC8104F1BE750025855A0042EF39
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/top-management-tactics-long-term-strategies-senior-biopharma-executives-steering-through-covid-19-beyond?opendocument
18
19opendocument
203.235.159.8
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Business Operations Strategic Planning and Management

Top Management Tactics & Long-Term Strategies for Senior Biopharma Executives Steering through COVID-19 and Beyond

ID: CM-5


Features:

13 Info Graphics

25 Data Graphics

870+ Metrics

22 Narratives


Pages: 48


Published: 2020


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Biopharma organizations - and the strategies of their senior leaders - must evolve to meet short-term threats and long-term challenges arising out of the COVID-19 health and economic crisis.

Best Practices, LLC conducted this benchmarking research to help senior biopharma executives audit the management tactics, top objectives, critical decision factors, investment patterns, cost control approaches, and future strategies being employed by their industry peers.

This report will help biopharma leaders make essential, evidence-based decisions to secure the health of their employees and the success of their organizations.

The report also analyzes the priorities and potential blindspots of both C-Suite Executives versus Function-Level Heads to ensure better communication, integrated strategy and optimal performance throughout all organizational levels.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consulting; Medical Device; Health Care; Technology; Clinical Research; Laboratories; Science


Companies Profiled:
Almirall; Apellis Pharmaceuticals; Astellas; Biofrontera; Biogen; Boehringer Ingelheim; Ferozsons Laboratories Limited; Halloran Consulting Group; Helsinn; Joerns Healthcare; Kala Pharmaceuticals; Inc.; Kaleo; Medacta USA; MEDiSTRAVA; Mint Pharmaceuticals Inc.; Mirador Analytics Ltd.; Monebo Technologies; Nevakar; Novartis; Nuvisan; Pfizer; Purdue Pharma; Samumed; Sandoz; Sanofi; Santen; SomaGenics Inc; Syneos Health; Takeda Pharmaceuticals; The Medical Affairs Company; Thermo Fisher Scientific; UCB Pharma; Vertex Pharmaceuticals; XG Sciences; Inc

Study Snapshot

Best Practices, LLC engaged 40 executives from 34 life science companies in this research through a benchmarking survey. Nearly 60% of surveyed participants served at the C-suite, President or Vice President level.

Key topics covered in this report include:

  • Top management objectives & effective day-to-day practices
  • Key financial & operational decisions being made
  • Key lessons & long-term opportunities
  • Management perspectives of Senior Executives vs. Function Heads


Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Top short-term priorities:

    • Health: Ensuring employee and patient health are top short-term goals
    • Ops & finance: Operations and financial considerations are 3rd and 4th among 12 surveyed senior-executive objectives
    • Digital transformation comes next, superseding immediate business results, external engagement strategy, innovation, alliances and regulatory
Table of Contents

Sr. No.
Topic
Slide No.
I.
Overviewp. 3
Universe of Learningp. 4
Key Takeaways to Guide Senior Execs During & After COVID-19p. 5
II.
Top Management Objectives & Effective Day-to-Day Practicesp. 7
III.
Key Financial & Operational Decisions Being Madep. 15
IV.
Long-term Opportunitiesp. 20
V.
Management Perspectives of Senior Executives vs Function Headsp. 28
VI.
APPENDIX A: Profile of Study Participantsp. 37
VII.
APPENDIX B: Additional Benchmark Datap. 40
VIII.
About Best Practices, LLCp. 48

    List of Charts & Exhibits

    I. Top Management Objectives & Effective Day-to-Day Practices

    • Ranking of each of the listed objectives for senior management on a day-to-day basis during this pandemic
    • Key short-term management objectives within benchmark organizations during this pandemic
    • Top management tactics and actions for achieving key management and organizational objectives
    • Executive voices from the field about COVID-19 task forces
    • Beneficial tactics in achieving key management and organizational objectives
    • Executive voices from the field on the action taken by organizations to provide effective leadership during the COVID-19 pandemic
    • Voices from the field around driving a strong communication loop

    II. Key Financial & Operational Decisions Being Made

    • Changes in investment patterns in response to the COVID-19 pandemic
    • New budget trends in response to COVID-19 pandemic
    • Ranking of effective cost cutting measures
    • Effectiveness of listed measures in reducing costs, while still maintaining strong performance and morale during the pandemic

    III. Long-term Opportunities

    • Ranking of key bellwethers
    • Importance of each of the listed indicators in driving critical organizational decisions
    • Interview narrative around weekly COVID-19 reports from key teams
    • Timeline to address new challenges & opportunities
    • Point at which benchmark organizations will begin to take action to meet new challenges and opportunities arising from the pandemic
    • Most important area to strengthen to capitalize on new long-term opportunities
    • Top advices from biopharma peers who are also managing through the COVID-19 pandemic

    IV. DATA SEGMENTATION: Comparing the Insights and Priorities of Senior Executives vs. Function Heads

    • Job titles of participants from Senior Executive segment and Function Head segment
    • Absolutely critical short-term management objectives for Senior Executives and Function Heads
    • Beneficial management tactics and actions for achieving key management and organizational objectives - Senior Executives vs. Function Heads
    • Key bellwethers in driving critical organizational decisions for Senior Executives and Function Heads
    • New budget investment policy - Senior Executives vs. Function Heads
    • Effective cost cutting measures - Senior Executives vs. Function Heads
    • Long-term objectives for Senior Executives and Function Heads
    • Addressing operational challenges and opportunities - Senior Executives vs. Function Heads